Name: Phencyclidine
Type: Hallucinogen
AKA: PCP, Sernylan
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
Phencyclidine (PCP), developed in the 1950s, was originally used as an anesthetic. It was withdrawn from clinical use due to its hallucinogenic and dissociative effects, but it remains a subject of research and has been used recreationally.
|
V. Legal Information
Phencyclidine (PCP), a dissociative drug, is classified as a Schedule II controlled substance in the US, allowing limited medical use but reflecting high abuse potential. It is similarly regulated in many countries due to its potent psychoactive effects and health risks. The UNODC emphasizes the need for balanced regulation to ensure safe medical use while preventing misuse.
US Federal Schedule - II
Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Phencyclidine (PCP) is a dissociative anesthetic with psychoactive effects. It acts as an upper, causing hallucinations and altered perception. Short-term use can lead to intense psychological effects, while long-term use may result in cognitive issues and dependence. Overdose risks include severe agitation, psychosis, and potential death. Safe use is difficult due to its potent effects. Recent research focuses on its impact on mental health and addiction. |
VII. Psychological Effects
Phencyclidine (PCP) affects mood and cognition by altering sensory perception and inducing dissociation. Immediate effects include hallucinations and mood changes. Long-term use can lead to persistent psychosis, cognitive impairments, and mood disorders. Recent research highlights its potential for severe psychological effects and long-term mental health issues.
|
VIII. Culture
Phencyclidine (PCP) was initially developed as an anesthetic in the 1950s but gained notoriety for its recreational use and dissociative effects. Its cultural significance includes its role in drug abuse and mental health issues. Proponents may discuss its use in medical research, while opponents emphasize its potential for misuse and severe side effects. Its impact is notable in discussions about drug abuse and mental health.
|